Hello!
I’m dr paul mainwaring
MBBS (Syd) MD (Lond) FRACP
Dr. Paul Mainwaring
MBBS (Syd) MD (Lond) FRACP
Brisbane, Australia
About dr paul mainwaring
MBBS (Syd) MD (Lond) FRACP
Dr Paul Mainwaring
Paul Mainwaring is a highly experienced medical oncologist with over 25 years of practice, focusing on basic, clinical, and translational research to provide personalized care to patients and their caregivers. He has contributed significantly to the field, publishing numerous papers in top cancer journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, and the Journal of Clinical Oncology.
After completing his medical oncology training at Royal Prince Alfred and Royal North Shore hospitals in Sydney, Paul Mainwaring moved to Europe’s largest cancer hospital, the Royal Marsden in London, where he earned his MD in cell death at the Institute of Cancer Research. In 1999, he was appointed a consultant at Guy’s, King’s, and St Thomas’ NHS Trusts.
In 2002, Paul Mainwaring returned to Australia to become the Director of Medical Oncology at Mater Adult Hospital. Later, in 2008, he moved to Queensland and continued his clinical and translational research in private practice. During his research work in Queensland, he discovered disruptive nanotechnologies that could revolutionize patient care.
In 2019, Paul decided to transition from his role as a medical oncologist and founded XING Technologies, where he currently serves as Co-Founder, Executive Chairman, and CEO. XING Technologies is a biotechnology company that specializes in developing ground-breaking and disruptive nanotechnology to provide rapid, point-of-care diagnosis, screening, and ongoing monitoring of cancer without needing access to laboratory facilities or highly trained personnel.
Paul completed his MBBS degree in Medicine from the University of Sydney, Australia, and his MD from the Institute of Cancer Research at the University of London, England.
Experience
Co-Founder, Executive Chairman & CEO
XING Group Holdings Pty Ltd
Brisbane, QLD Australia
February 2019 – Present
Consultant Medical Oncologist
Canossa Private Hospital, Oxley QLD
& Mater Hospital Gladstone, Gladstone QLD
July 2017 – February 2019
Consultant Medical Oncologist
Senior Principal Clinical Research Investigator
ICON Cancer Care (formerly known as Haematology & Oncology Clinics of Australia)
Level 5, Mater Medical Centre
293 Vulture Street
South Brisbane 4101
Queensland
July 2010- July 2017
Senior Principal Clinical Research Investigator
Mater Medical Research Institute
Raymond Terrace
South Brisbane 4101
Queensland
Australia
2007 – June 2010
Visiting Consultant Medical Oncologist; City & Regional affiliations
Haematology & Oncology Clinics of Australasia
293 Vulture St South Brisbane
Chermside Medical Centre, Chermside, Brisbane
Wesley Hospital, Auchenflower, Brisbane
Mater Hospital, Gladstone
Townsville Hospital, Townsville
Wesley Hospital, Townsville
Ipswich Hospital, Ipswich
2004
Mater Medical Research Institute Prof D Hart
Dendritic cell biology & immunotherapy for prostate cancer
UK
2003 – 2007
Director, Medical Oncology, Mater Health Services, Brisbane
Director, Medical Oncology Research
Co-developed electronic early referral system
Established formal multi-disciplinary led clinical care
Established formal multi-disciplinary clinics
Developed clinical research team in solid tumours; interaction with HREC
Developed translational research team
Reconfigure outpatient, day oncology unit care
Lead acquisition electronic prescribing system from proforma system
2003
NHS Consultant
NHS consultant position, Guy’s, King’s & St. Thomas’ Joint Cancer Centre with sub-speciality interests in gastro-intestinal malignancies and lymphomas. I have conjointly established a multidisciplinary team comprising medical, clinical, palliative and surgical oncologists, clinical, chemotherapy and research nurse specialists at GKTJCC in these sub-disciplines.
Managerial Positions:
NHS Information Authority National Minimum Dataset Committee
South East London Cancer Task Force Colorectal and Information Subcommittees
St Thomas Drug’s and Therapeutics Committee
South Thames Haematology Register – Lymphoma representative
GKTJCC Cancer management committee
October 1999 – November 2002
UK Laboratory Research Experience
MD in Medical Oncology
Prof. M Dowsett, Supervisor Dept. Academic Biochemistry The Institute of Cancer Research, University of London
September 1995 – August 1997
General Medical Training
1989-1992 Royal Prince Alfred Hospital, Sydney, Australia
Medical Oncology Training: Australia
1992 – 1994 Royal Prince Alfred Hospital, Sydney, Australia
Radiation Oncology Training: Australia
1994 The Royal North Shore Hospital, Sydney, Australia
Medical Oncology Training: United Kingdom
1995 – 1999 The Royal Marsden NHS Trust, London.
I’ve been grateful to give over 500 presentations.
contact dr paul mainwaring
DR PAUL MAINWARING
MBBS (Syd) MD (Lond) FRACP